Concepedia

Philip J. Lowe

PJ

39

Publications

3K

Citations

27

H-Index

1977

Active since

Affiliations

Novartis (Switzerland)(Current)

University of Birmingham

University at Buffalo, State University of New York

Novartis Institutes for BioMedical Research

United States Department of Veterans Affairs

Philip J. Lowe is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and liver physiology.

ORCID

Top concepts

Publications per year

1977–2022

39

Publications

39

In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes

Helen J. Lachmann, Philip J. Lowe, Sandra Daniela Felix et al. · The Journal of Experimental Medicine · 2009 · 291 citations · Full text

Pharmacokinetics, pharmacodynamics and safety of <scp>QGE</scp>031 (ligelizumab), a novel high‐affinity anti‐IgE antibody, in atopic subjects

Jonathan Arnold A. P., I. Bottoli, Andrej Skerjanec et al. · Clinical & Experimental Allergy · 2014 · 239 citations · Full text

Substitution of antibodies and receptors with molecularly imprinted polymers in enzyme-linked and fluorescent assays

Sergey A. Piletsky, Elena Piletska, Alessandra Bossi et al. · Biosensors and Bioelectronics · 2001 · 179 citations · Full text

, , +9

A mechanism‐based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab

Naoto Hayashi, Yuko Tsukamoto, William M. Sallas et al. · British Journal of Clinical Pharmacology · 2006 · 168 citations · Full text

Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection Against Proteases and Effect on Intestinal Absorption in Rats

Philip J. Lowe, Cathy S Temple · Journal of Pharmacy and Pharmacology · 1994 · 163 citations

Rows per page

1–5 of 39